Clinical trials
Clinical trials are research studies involving people that test health interventions, compare approaches, or collect evidence about safety and effectiveness. They are central to medicine, public health, drug development, devices, vaccines, behavioral care, and many treatment guidelines.
What clinical trials are
Clinical trials are research studies that involve people. They may test a drug, vaccine, device, surgery, behavioral program, diagnostic test, screening method, care model, or prevention strategy. A trial is designed around a specific question, such as whether an intervention is safe, whether it works, how it compares with standard care, or which people are most likely to benefit.
Clinical care and research
Clinical care is focused on helping an individual patient using established knowledge. Clinical research is designed to create generalizable knowledge. A trial may offer access to careful monitoring or a promising intervention, but its main purpose is to answer a research question. That distinction is why consent, oversight, and protocol rules matter.
Phases of trials
Trials for new drugs and some other interventions often move through phases. Phase 1 usually focuses on safety, dose, and how the body handles an intervention. Phase 2 looks for signals of effectiveness and further safety information. Phase 3 compares the intervention in larger groups and may support approval decisions. Phase 4 studies can monitor use after approval.
Designs and comparison groups
Some trials assign participants randomly to different groups. Randomization helps reduce bias by making groups more comparable. A control group may receive standard care, placebo, another active treatment, or a different strategy. Blinding can reduce bias when participants, clinicians, or researchers do not know which group a participant is in.
Eligibility and enrollment
Each clinical trial has eligibility criteria. These may include age, diagnosis, disease stage, prior treatments, lab values, pregnancy status, medications, genetic markers, health conditions, location, or timing. Criteria help protect participants and make results interpretable, but they can also limit who is represented in research.
Informed consent
Informed consent is more than signing a form. It is a process of learning about the study's purpose, procedures, possible risks, possible benefits, alternatives, privacy protections, costs, contacts, and the right to leave. Participants should have a chance to ask questions and decide voluntarily whether participation fits their situation.
Safety monitoring and oversight
Clinical trials are reviewed before they start, commonly by an institutional review board or ethics committee. Researchers follow a protocol that defines procedures and safety rules. Some studies also use data and safety monitoring boards, adverse-event reporting, stopping rules, and regulatory oversight to reduce avoidable harm.
Results and publication
Trial results can be published in journals, posted in registries, submitted to regulators, or used to shape future research. A trial can produce a positive, negative, mixed, or inconclusive result. Negative and inconclusive results still matter because they can prevent ineffective or harmful practices and guide better study design.
Limits and interpretation
A single trial rarely settles every question. Results depend on study design, sample size, follow-up time, participant diversity, outcome measures, missing data, adherence, and statistical uncertainty. A treatment that works in one group may not work the same way in another. Evidence usually becomes stronger when multiple well-designed studies point in the same direction.
Why it matters
Clinical trials matter because they turn hopeful ideas into evidence that can be checked. They help show which interventions are safe enough, which actually work, which cause harm, and which people may benefit. Without clinical trials, medicine would rely much more on anecdotes, tradition, marketing, and uncontrolled observation.